Submitted by Anonymous (not verified) on 29 June 2026 - 16:15
Human medicines European public assessment report (EPAR): Reyataz, atazanavir sulfate, Date of authorisation: 01/03/2004, Revision: 58, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Reyataz, atazanavir sulfate, Date of authorisation: 01/03/2004, Revision: 58, Status: Authorised